December 15, 2011
Yelena Novik, MD, FACP
Assistant Professor; Medical Director-Clinical Trials Office
Department of Medicine (Residency Program)
NYU Cancer Institute
Michael L. Pearl, MD, FACOG, FACS
Professor and Director
Division of Gynecological Oncology
Stony Brook University Hospital
Only 3 – 5% of adult cancer survivors participate in clinical trials; older adults and minorities are even less likely to do so. Increased participation in cancer-related trials benefits society by helping to develop and test the safety of new cancer treatments, and benefits participants who receive high quality cancer care. This Public Health Live webcast will address psychosocial, financial and other barriers to recruitment into cancer clinical trials, highlight the disparities that exist in terms of participation and identify NYS resources and strategies which may help lower barriers and reduce disparities.
Loading more stuff…
Hmm…it looks like things are taking a while to load. Try again?